retatrutide clinical trial brazil Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people retatrutide clinical trial brazil Eli

For patients already taking GLP-1 medications, there is no need for alarm

Long-term changes in cardiac structure and function following bariatric surgery

What are the most common side effects of oral semaglutide that patients should be aware of

Tirzepatide, the active ingredient in Mounjaro, is a complex peptide hormone that degrades when exposed to temperatures above 86F (30C)

Key Takeaways: Common Reactions : Redness, swelling, itching, bruises, or lumps (lasting up to a week)

The COR-I trial, involving 1,742 participants over 56 weeks, demonstrated 6.1% average weight loss with Contrave versus 1.3% with placebo (Greenway et al., Obesity, 2010)